Bortezomib in multiple myeloma and lymphoma: a systematic review and clinical practice guideline

@article{Reece2006BortezomibIM,
  title={Bortezomib in multiple myeloma and lymphoma: a systematic review and clinical practice guideline},
  author={Donna E. Reece and Kevin L Imrie and Adrienne L. Stevens and C Smith},
  journal={Current Oncology},
  year={2006},
  volume={13},
  pages={160 - 172}
}
QUESTIONS In patients with multiple myeloma, Waldenström macroglobulinemia, or lymphoma, what is the efficacy of bortezomib alone or in combination as measured by survival, quality of life, disease control (for example, time to progression), response duration, or response rate?What is the toxicity associated with the use of bortezomib?Which patients are… CONTINUE READING